Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
February 2014
Click for full info +Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
13 February 2014 |
In this Journal Article:
Health Risk(s):HIV HSV STI / STD
Product Type(s):Microbicides Vaginal Cream/Gel
Topic(s):Product Trials
Full Info:
Resource Type:
Citation:
McConville, C., Boyd, P., & Major, I. (2014). Clinical medicine insights. Women’s health, 7, 1.
Authors:
McConville, C., Boyd, P., & Major, I.
Health Risks(s):
- HIV
- HSV
- STI / STD
Product type(s):
- Microbicide
- VaginalCream
Topic(s):
- Trials
URL of resource: